8K released. I'll do extensive review later. At a glance....no new information regarding development. To try to get them to the next stage they are seeking $4 million to support drug manufacture and the FIH clinical trial with a follow on round of $10 million for early stage clinical development. Found it HILARIOUS that on their Current Company Profile & Comparisons slide they list the stock price at $0.26 as of September 5th. Talk about a coordinated effort lol.
Listen, I'm rooting for PPCB but what happened this week was utterly ridiculous. They need help getting to the P1 FIH study. They presented an old corporate slide that says the clinical trial application should already be approved yet they don't state that in the presentation. Frustrating. More later.
Market Data 
Markets 
AI
